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Abstract
Background: The development of mass spectrometric techniques and fractionation methods now
allows the investigation of very complex protein mixtures ranging from subcellular structures to
tissues. Nevertheless, this work is particularly difficult due to the wide dynamic range of protein
concentration in eukaryotic tissues. In this paper, we present a shotgun method whereby the
peptides are fractionated using OFFGEL electrophoresis after iTRAQ labelling.
Results: We demonstrated that iTRAQ peptide labelling enhances MALDI ionisation and that the
OFFGEL fractionation of the labelled peptides introduces a supplementary criterion (pI) useful for
validation and identification of proteins. We showed that iTRAQ samples allowed lower-
concentrated proteins identification in comparison with free-labelled samples.
Conclusion:  The combined use of iTRAQ labelling and OFFGEL fractionation allows a
considerable increase in proteome coverage of very complex samples prepared from total cell
extracts and supports the low-concentrated protein identification.
Background
The iTRAQ-reagent is well known for relative and absolute
quantitation of proteins [1-3]. The interest of this multi-
plexing reagent is that 4 or 8 analysis samples [4] can be
quantified simultaneously.
In this technique, the introduction of stable isotopes
using iTRAQ reagents occurs on the level of proteolytic
peptides. The iTRAQ technology uses an NHS ester deriv-
ative to modify primary amino groups by linking a mass
balance group (carbonyl group) and a reporter group
(based on N-methylpiperazine) to proteolytic peptides
via the formation of an amide bond. Due to the isobaric
mass design of the iTRAQ reagents, differentially-labelled
peptides appear as a single peak in MS scans, reducing the
probability of peak overlapping. When iTRAQ-tagged
peptides are subjected to MS/MS analysis, the mass bal-
ancing carbonyl moiety is released as a neutral fragment,
liberating the isotope-encoded reporter ions which pro-
vides relative quantitative information on proteins.
An inherent drawback of the reported iTRAQ technology
is due to the enzymatic digestion of proteins prior to
labelling, which artificially increases sample complexity.
Since it has been shown that a reliable determination of
protein dynamics requires quantitative evaluation of an
adequate set of proteolytic peptides derived from each
protein, the iTRAQ approach needs a powerful, multi-
dimensional fractionation method of peptides before MS
identification.
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Reported peptide separation methods include strong cat-
ion exchange (SCX) chromatography and reverse-phase
chromatography [5]. Recently, isoelectric focusing (IEF), a
high-resolution electrophoresis technique for separation
and concentration of amphoteric biomolecules at their
isoelectric point (pI), has been used in shotgun proteomic
experiments [6]. IEF runs in a buffer-free solution contain-
ing carrier ampholytes or in Immobilized pH gradient
(IPG) gels. Recently, the use of IPG-IEF for the separation
of complex peptide mixtures has been applied to the anal-
ysis of plasma and amniotic fluid [7,8] as well as to bacte-
rial material [9]. However, a major limitation of this
method is the tedious post-IEF sample processing. The
IPG gel strip is divided into small sections for extraction
and cleaning up of the peptides. A new concept called
OFFGEL electrophoresis was recently introduced with the
primary aim of purifying proteins and peptides [10]. This
technique recovers the sample from the liquid phase and
was demonstrated to be of great interest in shotgun pro-
teomics [11]. IEF is not only a high resolution and high
capacity separation method for peptides, it also provides
additional physicochemical information like their isoelec-
tric point [12,13]. The pI value provided is used as an
independent validating and filtering tool during database
search for MS/MS peptide sequence identification [14].
Recently, the compatibility of iTRAQ isotope labelling
and OFFGEL-IEF for relative quantification and validation
of sequence matches from database searching was shown
from a BSA tryptic digest sample and complex eukaryotic
samples [15,16] but surprisingly, no attempts was done to
undertake comprehensive analysis of influence of iTRAQ
labelling on the proteome coverage ratio.
In our work, we combined free-labelled peptides or
iTRAQ labelled peptides and OFFGEL fractionation for
the proteomic study of a very complex sample like the
human neuroblastoma SH-SY5Y cell line [17-19] in a
wide pI-range (pH 3–10) and compared the proteome
coverage between free-samples and iTRAQ-samples.
Results and discussion
The influence of iTRAQ-reagent tagging
The 2D-LC separation of 200 μg of free-labelled digested
proteins by SCX allowed identification of 159 proteins
among which 116 proteins were characterised by at least
2 peptides (73% performance) (Table 1, NL-116). From
four fractions of 50 μg of proteins which were reduced,
blocked with MMTS, digested with trypsin, labelled using
a different iTRAQ reagent, pooled and separated by SCX
chromatography (iTRAQ-310), 472 proteins can be iden-
tified. 310 out of these have been identified using at least
two peptides (Table 1). All the 116 proteins that were
identified without labelling (NL-116) were also identified
in the iTRAQ experiment. Nevertheless, iTRAQ labelling
allowed 2.7 more proteins identified (by at least 2 pep-
tides) compared to free-labelled experiments.
Increase in peptide mass following iTRAQ labelling
The presence of iTRAQ label on the NH2 terminal adds a
mass of 145 to the peptide m/z. If the peptide had a lysine
residue at the Cterm position, two iTRAQ labels are added
(290 Da). Looking at the list of peptides identified in the
iTRAQ-310 label experiment, 61 unique peptides without
lysine in their sequence had a m/z between 800 and 945,
and 55 other peptides with a lysine at the Cterm extremity
had a mass between 800 and 1090. These 116 peptides
were not visible without iTRAQ labelling; nevertheless,
they were found in the sequence of 60 proteins already
identified by at least 2 peptides. Only 3 proteins were
identified by a second peptide. The mass increase due to
iTRAQ-labelling cannot be the unique explanation of the
higher number of proteins identified nor the higher
number of peptides contributing to the identification for
each protein.
Table 1: The list of experiments and the number of identified proteins
Experiment Quantity (μg) Fractionation Labelling Total proteins Proteins with 2 peptides (at least) Yield (%)
NL-116 200 SCX no 159 116 73
NL-184 200 OFFGEL-IEF no 285 184 64
NL-235 200 SCX + OFFGEL-IEF no 302 235 78
iTRAQ-310 200 SCX iTRAQ 472 310 66
iTRAQ-429 400 SCX iTRAQ 492 429 87
iTRAQ-739 400 OFFGEL-IEF iTRAQ 879 739 84
All experiments: 1111 proteins, with 2 pept: 947 proteinsProteome Science 2008, 6:27 http://www.proteomesci.com/content/6/1/27
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iTRAQ increases ionisation of peptides containing lysines
Analysis of the non-labelled peptide sequences showed
that 20% of them had a lysine termination, and 80% an
arginine termination (Figure 1). A recent study demon-
strated that during MALDI ionisation, there is a linear cor-
relation between peptide ionisation levels and the proton
affinity of the amino acids, with the exception of lysine
[20]. Arginine is the residue having the strongest proton
affinity, and peptides containing this amino acid are those
ionising the best. This conclusion is in line with our
results; peptides containing arginine had better ionisation
levels, therefore providing a better signal to noise ratio for
simple MS, and thus providing higher quality MS/MS
spectra responsible for more valid sequence identification
than peptides having a Cterm lysine.
The analysis of peptides identified following iTRAQ label-
ling showed a balance of the number of arginine- or
lysine-terminated peptides with 50% arginine-terminated
and 50% lysine-terminated (Figure 1). Our results con-
firm those of Ross [1] who showed that in comparable
whole-yeast experiments using electrospray, (much less
sensitive to proton affinity than MALDI ionisation), the
ratio of lysine to arginine-terminated peptides identified
increased from 0.79 for native peptide, to 0.98 for iTRAQ
derived peptides. The reporter group of the iTRAQ reagent
is a piperazine group having 2 tertiary amines groups. By
attaching these onto the lysine's lateral chain, a primary
amine function is thereby replaced by two tertiary amine
functions. We know that tertiary amines have a stronger
proton affinity than the one primary amines (about 50 kJ/
mole). By introducing 2 tertiary amine functions on pep-
tides having lysines, their proton affinity and therefore
their ionisation increase. For example, Figure 2 shows MS/
MS spectra of the peptide GALQNIIPASTGAAK before and
after iTRAQ labelling. The signal/noise ratio is multiplied
by 6 for the most intense y8 ion. This result suggests that
the proton affinity of iTRAQ modified lysines is almost
equal to the one of arginines. We found that iTRAQ gave
equivalent identification success rate for arginine- and
lysine-terminated peptides, hence increasing the peptide
coverage of proteins and increasing the chance of identify-
ing low-concentration peptides.
The influence of the quantity of iTRAQ-labelled peptides
From only 400 μg of reduced, blocked, digested cellular
lysate labelled using iTRAQ, we were able after SCX sepa-
ration to identify, 492 proteins, of which 429 with at least
2 peptides, giving an identification rate of 87% (iTRAQ-
429). By doubling the amount of biological material to
iTRAQ labelling favours the peptide ionization Figure 1
iTRAQ labelling favours the peptide ionization. Number of identified peptides with a lysine or an arginine in the C-term 
position; white bars: free-labelled peptides; black bars: iTRAQ peptides.
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MS/MS spectra of GALQNIIPASTGAAK (which allowed the identification of the Glyceraldehyde 3 phosphate deshydrogenase)  from 200 μg of digested proteins fractionated by SCX chromatography Figure 2
MS/MS spectra of GALQNIIPASTGAAK (which allowed the identification of the Glyceraldehyde 3 phosphate 
deshydrogenase) from 200 μg of digested proteins fractionated by SCX chromatography. (A) free-labelled exper-
iment; (B) iTRAQ labelling experiment.
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start with, identification rate for proteins with at least 2
peptides raised by 39% (Table 1).
The influence of the fractioning method on free-labelled 
peptides
The OFFGEL technology of 200 μg of free-labelled
digested proteins allowed identification of 285 proteins,
including 184 with at least 2 peptides (NL-184). By look-
ing at the number of fractions in which each distinct pep-
tide is found we can judge the fractionation quality of the
technique. Figure 3 shows that 84% of the identified pep-
tides are found in only one fraction and more than 95%
are found in one or two fractions. This result is in agree-
ment with the results found from earlier studies [21]. The
average experimental pH value of each fraction is pre-
sented as a bar in Figure 4A. The theoretical pH values pro-
vided by the manufacturer were overlaid as a broken line.
Average experimental pH values deviated from theoretical
values by an average error of 0.29 pI unit. Only fractions
close to neutrality (Fractions F12 to F18), and which do
not contain a large number of peptides, showed an error
of 0.38 pI unit in agreement with already published
results [22]. Such an error was also found for the 3 more
acidic fractions F1 to F3. For these 3 fractions, the error is
largely due to the Bjellqvist algorithm [12] which is used
in this study. This algorithm is known to overestimate pI
values in the acidic range [22]. One feature of this experi-
ment is that after screening with our previously-described
criteria, no peptide was identified in fraction 24 (Figure
4B); this is in line with Fraterman's work [23]. In order to
verify the identification of the peptides set and decrease
false positive percentage after ProteinPilot calculations,
we used the pI peptide property as an orthogonal property
of these peptides of interest [24]. By separating peptides
using OFFGEL, we showed that we can predict their pI
with an accuracy of 0.4 pI unit. Under this condition, all
peptides with unused ProteinPilot score > 1.3 and show-
ing an experimental pI deviating by more than 0.4 pI unit
from calculated value were excluded. All free-labelled pep-
tides presented in this work were filtered according to
their ProteinPilot unused score and pI as described above.
The quality of OFFGEL separation of iTRAQ-labelled 
peptides
By using OFFGEL separation by 24 fractions of 400 μg of
iTRAQ-labelled peptides, we identified 879 proteins, of
which 739 with at least 2 peptides (iTRAQ-739), giving an
increase of 72% (Table 1) compared to SCX separation.
Fractionwise distribution of identified SH-SY5Y peptides Figure 3
Fractionwise distribution of identified SH-SY5Y peptides. white bars: free-labelled peptides; black bars: iTRAQ pep-
tides.
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Analysis of SH-SY5Y peptides pI after OFFGEL fractionation and MALDI- MS/MS identification Figure 4
Analysis of SH-SY5Y peptides pI after OFFGEL fractionation and MALDI- MS/MS identification. (A) The average 
experimental pH of all peptides in a single fraction after filtering for false positive is presented as bars; white bars: non-labelled 
peptides; dark bars: iTRAQ peptides. Error bars indicate the SD of each fraction's experimental pI. The broken line is based on 
the theoretical pI values for an IPG strip of 24 cm ranging from pH 3–10; Agilent Technologies provided the theoretical pI val-
ues. (B) The total bar height shows the number of peptides in each fraction after filtering for false positive; white bars: non-
labelled peptides; black bars: iTRAQ peptides.
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OFFGEL experiment also increased the number of pep-
tides identified per protein from 4.8 (iTRAQ-429) to 7.1
(iTRAQ-739), thereby increasing dramatically the confi-
dence level of the protein identification. Figure 5 shows
the quantity of proteins identified with different numbers
of matching peptides with the two types of fractionation.
We can see that OFFGEL gave a higher number of proteins
identified in all fractions.
As shown in Figure 3, 78% of the identified peptides are
found in only one fraction and about 90% are found in
one or two fractions, confirming the distribution of free-
labelled peptides in our work and the results from earlier
studies [16,21].
The distribution of peptides per fraction is shown in Fig-
ure 4. The pI value for each identified peptide was calcu-
lated by using Bjellqvist's algorithm without taking into
account the iTRAQ groups in N-term position and/or on
the lateral lysine chain. Using these data, average pI values
with standard deviations were calculated for all peptides
identified in each fraction (Figure 4A). The average exper-
imental pI value deviated from the theoretical pI value by
an average error of +/- 0.43. In the pH range of 3 to 8, the
average pI value of the labelled peptides fits very well with
the average value of the non-labelled peptides. Major
deviations were observed at the basic pH range (8.3–10.0)
for fractions 18–24. By splitting OFFGEL fractionation
into 2 zones, we noticed that the mean error in the pH 3–
8 range was +/- 0.34 and was rising to +/- 0.64 in the more
alkaline range (pH 8–10); this can probably be explained
by the fact that the software used for calculating the pI
value does not take into account the presence of the
iTRAQ label. As for the free-labelled peptides, we intro-
duced the pI iTRAQ-labelled peptides property as a filter
to verify the identification of the set of peptides. For the
fractions F1 to F17 (pH 3.3–8.0 range), all peptides with
an unused ProteinPilot score above 1.3 and with an exper-
imental pI difference larger than 0.4 pI unit were
excluded. For the fractions F18-F24 (pH 8.3–10.0), we
excluded all peptides with experimental pI difference
greater than 0.7 pI unit. All iTRAQ-labelled peptides pre-
sented in this work were filtered using this protocol.
The distribution of identified proteins based on the number of peptides used for protein identification Figure 5
The distribution of identified proteins based on the number of peptides used for protein identification. Compar-
ison between SCX and OFFGEL fractionation of iTRAQ samples.
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Proteomic coverage
Combining results of all experiments, we end up with 947
proteins (Additional file1) identified with at least 2 pep-
tides and 6119 unique peptides. 380 detected proteins
have at least 5 or more unique peptides identified.
The proteins observed in our experiments were mapped in
relation with their MW and pI. The distribution of pI val-
ues over a range of 3–12 is shown in Figure 6. Similar to
previous computational analyses [25,26] our results show
that the distribution of the predicted pI values of our iden-
tified proteins is typical of eukaryotic cells, showing a kind
of tri-modal distribution. The pI value distribution of our
identified proteins shows the same profile as the distribu-
tion of human proteins identified from epithelial mam-
mary cells (quite different from human proteome) [25].
Our results show a fairly good coverage for both cytosolic
and membrane proteins. Indeed, the coverage is slightly
biased towards the identification of cytosolic proteins
(cluster at pI 6), presumably due to a better solubility of
cytosolic proteins compared to membrane proteins (clus-
ter at pI 9). Improved coverage of membrane proteins
from plasma membrane and subcellular organelles can be
achieved by coupling OFFGEL with further subcellular
fractionation and better membrane-solubilising strate-
gies. The molecular weight (MW) distribution of the iden-
tified proteins is shown in Figure 7. The overall trend of
the MW distribution of the identified proteins versus the
human proteome is very similar, even if proteins in the
<20 kDa range is slightly higher suggesting there is no real
bias in our protocol.
By comparing MW profiles of the proteins identified in
the iTRAQ-947 and iTRAQ-739 experiments, we can see
that the profiles are comparable (Figure 7), strengthening
the hypothesis that the iTRAQ-739 experiment correctly
reflects proteome coverage of the cell line SH-SY5Y.
Relative abundance of proteins
One way to get an idea of the quantity of a protein in a
complex mixture is to calculate its PAI [27], which repre-
sents the number of identified peptides divided by the
number of theoretical tryptic peptides. The PAI mean
value for the iTRAQ-947 experiment is 0.32; 50% of the
proteins have a PAI value < 0.14 and 21% have a PAI value
< 0.05, a characteristically value for proteins present at
low concentration. Some of these low abundance proteins
such as Transcription factor BTF3 homologue 4, Tran-
Protein distribution in function of pI Figure 6
Protein distribution in function of pI. The isoelectric point distribution of SH-SY5Y proteins identified with 2 or more 
peptides.
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scription initiation factor IIF sub-unit beta, and Nuclear
factor 1 B-type are identified in this range of low PAI lev-
els. The comparison between an experiment without
labelling and an experiment with iTRAQ labelling, using
similar method of separation, shows a higher number of
proteins identified in each category for iTRAQ-labelled
proteins (Figure 8A). This result is particularly convincing
when looking at very low PAI values, and hence at pro-
teins present at low concentration. In the area of PAI levels
lower than 0.05, only 2 proteins were identified in the
non-labelling experiment, compared to 44 identified fol-
lowing iTRAQ labelling. We carried out comparisons for
similar PAI values for SCX-C18/2D-LC and OFFGEL-IEF
fractionation. Starting with only 400 μg of proteins with
iTRAQ labelling, we demonstrated that OFFGEL-IEF sepa-
ration gives the largest number of identified proteins, par-
ticularly in areas with low PAI values (Figure 8B). By
comparing the PAI values of proteins identified with at
least 2 peptides in the different experiments, we can
clearly see the superiority of iTRAQ labelling in compari-
son to non-labelled molecules, and the superiority of the
OFFGEL-IEF fractionation method as compared to the
SCX-C18/2D-LC method.
Conclusion
iTRAQ is at evidence a very powerful tool, recognised for
its ability to relatively quantify proteins. In this work, we
showed that the iTRAQ reagent improves MALDI ionisa-
tion, especially for peptides containing lysine. A direct
consequence of this property is the better chance of iden-
tifying low abundance proteins in complex biological
materials. We were also able to demonstrate that an OFF-
GEL fractionation step, has a positive influence on the
number of proteins identified compared to SCX method.
From standard clinical protein quantities (400 μg), we
proposed a methodology allowing the identification of
more than 800 proteins. Having established a protein
Protein distribution in function of MW Figure 7
Protein distribution in function of MW. The molecular weight distribution of SH-SY5Y proteins identified with two or 
more peptides; white bars: from one experiement with 400 μg of digested proteins and labelled with iTRAQ reagent ; black 
bars: from all the experiments
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Protein abundance index (PAI) for the identified proteins Figure 8
Protein abundance index (PAI) for the identified proteins. (A) influence of the iTRAQ labelling: free-labelled vs iTRAQ 
peptides (from 200 μg of digested proteins fractionated by SCX chromatography); (B) influence of the fractionation mode: 
SCX vs OFFGEL (from 400 μg of digested proteins and labelled with iTRAQ reagent).
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database of SH-SY5Y cells, we can now use it as a reference
for further research in this domain.
Materials and methods
Cell culture and protein extraction
The human neuroblastoma cell line SH-SY5Y was a gift
from Dr F. Vallette (INSERM U601, Nantes, France). Cells
were grown in RPMI-1640 medium (Lonza) supple-
mented with 10% (v/v) fetal bovine serum (Lonza) with-
out antibiotics in a, 5% humid CO2 atmosphere at 37°C.
Cells were scraped and washed 3 times with PBS (300 × g,
5 min.). Cell pellets were then lysed by a solution contain-
ing 7M urea, 2M thiourea, 4% (w/v) CHAPS at 4°C for 1
h using a rotary shaker. Lysis was achieved by sonication
on ice (3 × 5s pulses), and the lysates were clarified by cen-
trifugation at 14,000 × g at 4°C for 15 min.
Protein digestion and peptide labelling with iTRAQ 
reagents
Protein samples were cleaned up by precipitation with 6
volumes of cold acetone at -20°C overnight followed by
resuspension of pellets in 0.5M triethylammonium bicar-
bonate (TEAB) pH 8.5 (Sigma-Aldrich) and final centrifu-
gation step at 14,000 × g at 4°C for 15 min. We quantified
proteins from supernatant with the 2-D Quant Kit (GE
Healthcare, München, Germany) before diluting the pro-
tein samples up to 5 mg/ml with TEAB buffer. We took 50
or 100 μg of proteins for further reduction, alkylation,
digestion and iTRAQ labelling using iTRAQ Reagents Mul-
tiplex Kit (Applied Biosystems) according to manufac-
turer's protocol. Briefly, protein samples were reduced
with 5 mM tris-(2-carboxyethyl)phosphine (TCEP) at
60°C for 1 h. and the cysteine-groups were blocked using
a 10 mM methyl methanethiosulfonate (MMTS) solution
at room temperature for 10 min. . The proteins were then
digested by 10 μg of trypsin at 37°C for 16 h. Each peptide
solution was labelled at room temperature for 1 h with
one iTRAQ reagent vial (mass tag 114, 115, 116 or 117)
previously reconstituted with 70 μl of ethanol. Samples of
the same protein content, and labelled respectively with
114, 115, 116 and 117 iTRAQ reagents, were combined
and labelling reaction stopped by evaporation in a Speed
Vac to obtain a brown pellet.
Peptide OFFGEL fractionation
For pI-based peptide separation, we used the 3100 OFF-
GEL Fractionator (Agilent Technologies, Böblingen, Ger-
many) with a 24-well set-up. Prior to electrofocusing,
samples were desalted onto a Sep-Pak C18 cartridge
(Waters). For 24-well set-up, peptide samples were diluted
to a final volume of respectively 3.6 mL using OFFGEL
peptide sample solution. To start, the IPG gel strips of 24
cm-long (GE Healthcare, München, Germany) with a 3–
10 linear pH range were rehydrated with the Peptide IPG
Strip Rehydradation Solution according to the protocol of
the manufacturer for 15 min. Then, 150 μL of sample was
loaded in each well. Electrofocusing of the peptides is per-
formed at 20°C and 50 μA until the 50 kVh level was
reached. After focusing, the 24 peptide fractions were
withdrawn and the wells rinsed with 200 μL of a solution
of water/methanol/formic acid (49/50/1) after 15 min,
the rinsing solutions were pooled with their correspond-
ing peptide fraction. All fractions were evaporated by cen-
trifugation under vacuum and maintained at -20°C. Just
prior nano-LC, the fractions were resuspended in 20 μL of
H2O with 0.1% (v/v) TFA.
Capillary LC separation
The samples were separated on an Ultimate 3,000 nano-
LC system (Dionex, Sunnyvale, USA) using a C18 column
(PepMap100, 3 μm, 100A, 75 μm id × 15 cm, Dionex) at
a flow rate of 300 nL/min. . Buffer A was 2% ACN in water
with 0.05% TFA and buffer B was 80% ACN in water with
0.04% TFA.
Peptides were desalted for 3 min. using only buffer A on
the precolumn, followed by a separation for 60 min. using
the following gradient: 0 to 20% B in 10 min., 20% to
55% B in 45 min. and 55% to 100% B in 5 min. Chroma-
tograms were recorded at the wavelength of 214 nm. Pep-
tide fractions were collected using a Probot microfraction
collector (Dionex).
For the SCX fractionation, we used a salt gradient steps:
20-μl injections of 5 mM, 10 mM, 25 nM, 50 mM, 75
mM,100 mM, 125 mM, 150 mM, 200 mM, 300 mM, 500
mM, 1000 mM NaCl
We used CHCA (LaserBioLabs, Sophia-Antipolis, France)
as MALDI matrix. The matrix (concentration of 2 mg/mL
in 70% ACN in water with 0.1% TFA) was continuously
added to the column effluent via a micro "T" mixing piece
at 1.2 μL/min flow rate. After 14 min run, a start signal
was sent to the Probot to initiate fractionation. Fractions
were collected for 10s and spotted on a MALDI sample
plate (1,664 spots per plate, Applied Biosystems, Foster
City, CA).
MALDI-MS/MS
MS and MS/MS analyses of off-line spotted peptide sam-
ples were performed using the 4800 MALDI-TOF/TOF
Analyser (Applied Biosystems). After screening of all LC-
MALDI sample positions in MS-positive reflector mode
using 1500 laser shots, the fragmentation of automati-
cally-selected precursors was performed at collision
energy of 1 kV using air as collision gas (pressure of ~2 ×
10-6 Torr). MS spectra were acquired between m/z 800 and
4000. For internal calibration, we used the parent ion of
Glu1-fibrinopeptide at m/z 1570.677 diluted in the matrix
(3 femtomoles per spot). Up to 12 of the most intense ionProteome Science 2008, 6:27 http://www.proteomesci.com/content/6/1/27
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signals per spot position having a S/N > 12 were selected
as precursors for MS/MS acquisition. Peptide and protein
identification were performed by the ProteinPilot™ Soft-
ware V 2.0 (Applied Biosystems) using the Paragon algo-
rithm [28]. Each MS/MS spectrum was searched for Homo
sapiens specie against the Uniprot/swissprot database
(release 51 of October 2006). The searches were run using
with the fixed modification of methylmethanethiosulfate
labelled cysteine parameter enabled. Other parameters
such as tryptic cleavage specificity, precursor ion mass
accuracy and fragment ion mass accuracy are MALDI 4800
built-in functions of ProteinPilot software.
The ProteinPilot software calculates a confidence percent-
age (the unused score) which reflects the probability that
the hit is a false positive, meaning that at 95% confidence
level, there is a false positive identification chance of
about 5%.
While this software automatically accepts all peptides hav-
ing an identification confidence level >1%, only proteins
having at least one peptide above 95% confidence were
initially recorded. The low confidence peptides cannot
give a positive protein identification by themselves, but
may support the presence of a protein identified using
other peptides with higher confidence. Performing the
search against a concatenated database containing both
forward and reversed sequences allowed estimation of the
false discovery rate below1%.
The experimental pI for each peptide was calculated using
a pI/Mw tool of the ExPASy Proteomic Server [12,29].
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